| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/29/2006 | CA2589647A1 Glp-1 analog fusion protein formulations |
| 06/29/2006 | CA2588966A1 Cladribine regimen for treating multiple sclerosis |
| 06/29/2006 | CA2588911A1 Therapeutic nutrient compositions or combinations and methods of their use |
| 06/29/2006 | CA2587985A1 Peptides for use in treatment in fever or pain |
| 06/28/2006 | EP1674576A1 Recombinant allergen with reduced enzymatic activity |
| 06/28/2006 | EP1674575A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/28/2006 | EP1674477A2 Binding polypeptides for B lymphocyte stimulator protein (BLYS) |
| 06/28/2006 | EP1674475A1 Process for the preparation of a powder containing glucopyranosyl-alditols cristalline particules |
| 06/28/2006 | EP1674115A1 Semi-synthetic platelet gel and method for the preparation thereof |
| 06/28/2006 | EP1674110A1 Inhibition of bradykinin release |
| 06/28/2006 | EP1674109A1 Remedy for kidney diseases |
| 06/28/2006 | EP1674108A2 Osteoporosis treatment |
| 06/28/2006 | EP1674107A2 Use of daptomycin |
| 06/28/2006 | EP1674102A1 Use of flibanserin in the treatment of sexual disorders |
| 06/28/2006 | EP1674082A1 Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament |
| 06/28/2006 | EP1673633A1 Method and device for detecting feline immunodeficiency virus |
| 06/28/2006 | EP1673468A2 Methods for identifying compounds for inhibiting fever |
| 06/28/2006 | EP1673464A2 Conjugation of peptides |
| 06/28/2006 | EP1673458A1 Poxvirus vector encoding retrovirus (eg hiv) and cytokine |
| 06/28/2006 | EP1673457A2 Novel fungal proteins and nucleic acids encoding same |
| 06/28/2006 | EP1673456A1 Soluble ectodomain fragments of met and uses thereof |
| 06/28/2006 | EP1673453A2 Hybrid molecules having factor vii/viia activity |
| 06/28/2006 | EP1673450A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 06/28/2006 | EP1673388A2 Novel cxcl8 antagonists |
| 06/28/2006 | EP1673387A1 Il-21 derivatives |
| 06/28/2006 | EP1673385A1 Macrocyclic peptides active against the hepatitis c virus |
| 06/28/2006 | EP1673105A1 Use of follicle stimulating hormone for reduction of spermatozoa chromosomal aberration in males |
| 06/28/2006 | EP1673104A2 Delivery of therapeutic compounds to the brain and other tissues |
| 06/28/2006 | EP1673103A1 Therapeutic uses of chemokine variants |
| 06/28/2006 | EP1673102A1 Treatment and prevention of decubitus |
| 06/28/2006 | EP1673101A1 Lim2 inhibitors of lmo2 |
| 06/28/2006 | EP1673099A1 Compositions and methods for inhibiting cell senescence and hyperproliferative disorders |
| 06/28/2006 | EP1673070A1 Preparation method for sustained release microspheres using a dual-feed nozzle |
| 06/28/2006 | EP1597370B1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 06/28/2006 | EP1492561B1 Methods for treating mammary gland disorders |
| 06/28/2006 | EP1383897B1 Self-containing lactococcus strain |
| 06/28/2006 | EP1372694B1 Liposome targeting of matrix metalloproteinase inhibitors |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1268405B1 Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents |
| 06/28/2006 | EP1254159B9 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides |
| 06/28/2006 | EP1224290B1 Disulfide conjugated cell toxins and methods of making and using them |
| 06/28/2006 | EP1218508B1 DNA sequences for the enhancement of feed efficiency and growth rate of pigs |
| 06/28/2006 | EP1214452B1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/28/2006 | EP1157034B1 Process for production of diphtheria toxin |
| 06/28/2006 | EP1142905B1 Novel depsipeptide compound |
| 06/28/2006 | EP1133571B1 Methods and compositions for pain management |
| 06/28/2006 | EP1062237B1 Ribonucleotide polypeptides containing metal |
| 06/28/2006 | EP1060251B1 Phosphodiesterase 10 |
| 06/28/2006 | EP1040185B9 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 06/28/2006 | EP1017364A4 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 06/28/2006 | EP1011638A4 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 06/28/2006 | EP0936919B1 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE |
| 06/28/2006 | EP0897426B1 Matrix metalloprotease |
| 06/28/2006 | EP0895543B1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 06/28/2006 | EP0882799B1 Anti-human vegf receptor flt-1 monoclonal antibody |
| 06/28/2006 | EP0832227B9 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 06/28/2006 | EP0797676B9 Recombinant adenoviral vector and methods of use |
| 06/28/2006 | EP0787138B1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 06/28/2006 | EP0783585B1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 06/28/2006 | EP0727490B1 Human-origin prostacyclin synthase |
| 06/28/2006 | EP0693129B1 Method of inhibiting the transcription of genes |
| 06/28/2006 | EP0675732B1 Use of relaxin in the manufacture of therapeutic agents |
| 06/28/2006 | CN1795214A Higher molecular modifier and medicinal composition |
| 06/28/2006 | CN1795206A Galectin 9-inducing factors |
| 06/28/2006 | CN1795205A Spex compositions and methods of use |
| 06/28/2006 | CN1795204A Method for the extraction of deer antler |
| 06/28/2006 | CN1795188A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/28/2006 | CN1795173A Captopril derivatives |
| 06/28/2006 | CN1795012A Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 06/28/2006 | CN1795008A Histamine binding compounds for treatment method for disease conditions mediated by neutrophils. |
| 06/28/2006 | CN1795007A Methods and compositions for the treatment of gastrointestinal disorders |
| 06/28/2006 | CN1795005A Medicine health-care usage of globefish I collagen extration and preparing process thereof |
| 06/28/2006 | CN1794995A Use of tyrosine kinase inhibitor to treat diabetes |
| 06/28/2006 | CN1793175A Cell shifting related protein and its coding gene and application |
| 06/28/2006 | CN1793173A Process for preparing agglutinin of loranthyl |
| 06/28/2006 | CN1793170A Polypeptide of inhibiting HIV virus fusion and application thereof |
| 06/28/2006 | CN1792222A Process for the preparation of a powder containing glucopyranosyl-alditols cristalline particules |
| 06/28/2006 | CN1261592C Antigen polypeptide of IC53 gene product, use of auto-body in diagnosis and treating of arrhythmia cardimyopathy and reagent kit containing the polypeptide |
| 06/28/2006 | CN1261579C Hybrid proteins which form heterodimers |
| 06/28/2006 | CN1261570C Actinia neurotoxin gene and its application |
| 06/28/2006 | CN1261566C Method for preparing non-receptor type tyrosine protein kinase Syk |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261452C Sugar conjugated material CHB extracted from serum of turtle or/and tortoise, preparation process and application in pharmacy thereof |
| 06/28/2006 | CN1261450C Antithrombotic compounds |
| 06/28/2006 | CN1261449C Melanocyte-stimulating hormone inhibitors |
| 06/28/2006 | CN1261159C Freeze dried powder injection of hirudin and its preparation method |
| 06/28/2006 | CN1261158C Application of growth hormone for preparation medicine with induced nerve protection function |
| 06/28/2006 | CN1261157C Pharmaceutical composition with liver cell protecting function |
| 06/28/2006 | CN1261142C Use of a serra repens extract for the production of a medicament to treat prostate cancer |
| 06/27/2006 | US7067713 C1 Inhibitor produced in the milk of transgenic non-human mammals |
| 06/27/2006 | US7067646 Methods and compositions for modulating tumor suppression |
| 06/27/2006 | US7067639 Method to provide bacterial ghosts provided with antigens |
| 06/27/2006 | US7067637 having mitogenic and/or differentiation-inductive, e.g. osteo-inductive potential, which is coded by DNA sequences coding for new members of the TGF- beta protein family |
| 06/27/2006 | US7067636 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents |
| 06/27/2006 | US7067635 For use in diagnostic methods, immunotherapy, gene therapy and as vaccines |
| 06/27/2006 | US7067633 mutant dynein light chain-1/protein inhibitor of nitric oxide synthase polypeptide; comprises a DLC1/PIN polypeptide lacking serine 88 of DLC1/PIN, a DLC1/PIN polypeptide lacking the C-terminal 19 amino acids of DLC1/PIN, and/or a DLC1/PIN polypeptide lacking the C-terminal 23 amino acids of DLC1/PIN |
| 06/27/2006 | US7067632 VP22 proteins and uses thereof |
| 06/27/2006 | US7067630 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 06/27/2006 | US7067629 Sodium channel in dorsal root ganglia |
| 06/27/2006 | US7067626 Human ion channel proteins |